Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder (ADHD) [4] is a neurodevelopmental disorder characterized by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate.
The use of stimulant medication for treatment of attention-deficit hyperactivity disorder (ADHD) is well-researched and considered one of the most effective treatments in psychiatry. [89] A 2015 study examined the long-term effects of stimulant medication for ADHD, and reported that stimulants are a highly effective treatment for ADHD in the ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by executive dysfunction. It has effects on attention span, cognition, self-control, and emotional regulation.
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury.
ADHD, ODD, and CD were previously classified in the Attention-deficit and Disruptive Behavior Disorders section in DSM-IV. [41] Pyromania, kleptomania, and IED were previously classified in the Impulse-Control Disorders Not Otherwise Specified Section of DSM-IV.
The prevalence of attention deficit hyperactivity disorder was found to be 3.4% overall in Riyadh, Saudi Arabia, among primary school students between the years of 2015 and 2016, with 22 children having symptoms that were both reported by their parents and teachers. The gender split among them was 3:1, with 13 (5.7%) boys and 9 (2.1%) girls. [17]
ADDitude magazine is a quarterly consumer publication about attention deficit hyperactivity disorder (ADHD or ADD) owned and operated by WebMD, LLC in New York, NY. It contains feature and service articles about ADD, ADHD and comorbid conditions including depression, anxiety, and learning disabilities like dyslexia.